Autosomal dominant polycystic kidney disease (ADPKD) is a genetic condition marked by progressive cyst growth and, ultimately, kidney failure. While the underlying mutations are inherited, growing research suggests that modifiable lifestyle factors, such as diet, body weight, and metabolic health, can significantly influence ADPKD progression. A wave of recent studies is helping to define which interventions may help slow the march toward kidney failure, offering renewed hope for patients seeking preventive strategies.
This article summarizes five key studies that examine the relationship between lifestyle factors and the progression of ADPKD.
By Majd Isreb, MD, FACP, FASN, IFMCP
Obesity’s Role Depends on Disease Stage
Drawing on data from the HALT-PKD trials, researchers found that obesity was associated with a significantly increased risk of ESKD in early-stage ADPKD patients (eGFR ~91 mL/min/1.73m²), but not in late-stage patients (eGFR ~48 mL/min/1.73m²).
This stage-specific effect highlights a potential therapeutic window during the early course of the disease when weight management could have the most significant impact. Early intervention may help reduce cyst growth and slow structural kidney damage before irreversible decline sets in.
Lower BMI Linked to Slower ADPKD Progression
Another cross-sectional study of 3,556 patients with ADPKD from the US Renal Data System and the Japanese Society for Dialysis Therapy revealed that patients in Japan, who had significantly lower average BMI (22.0 vs. 28.2 kg/m²), initiated renal replacement therapy (RRT) at a later age (61.6 vs. 56.6 years, P<.001). The analysis revealed that a lower BMI was independently associated with a delayed onset of end-stage kidney disease (ESKD), even after adjusting for confounding variables and across ethnic subgroups.
This finding reinforces the importance of body weight as a modifiable factor in ADPKD. While genetics drives cyst formation, metabolic health may shape how rapidly the disease progresses. The study also suggests that national lifestyle and dietary patterns can significantly influence outcomes.
Time-Restricted Eating: A Pilot Study with Mixed Outcomes
In a 12-month randomized trial, researchers investigated whether time-restricted eating (TRE), which involves consuming all meals within an 8-hour window, could affect kidney volume or weight in patients with ADPKD. Compared to a control group that received general healthy eating guidance, both groups achieved modest weight loss. However, there was no significant difference in total kidney volume changes, as measured by MRI.
The results suggest that the benefits of TRE may stem more from general weight reduction than from meal timing itself. Although this trial was limited in size and duration, it contributes to the growing evidence that lifestyle modification, particularly involving caloric intake and weight control, can help manage ADPKD progression.
Join us to end the kidney disease epidemic
Silent Stones Accelerate Decline in Kidney Function and ADPKD Progression
A retrospective cohort study involving 195 patients with ADPKD found that those with asymptomatic kidney stones experienced a significantly faster decline in estimated glomerular filtration rate (eGFR) compared to those without nephrolithiasis. The presence of kidney stones independently predicted poorer outcomes.
This finding challenges the assumption that asymptomatic stones are clinically insignificant. Proactive monitoring and management of nephrolithiasis, including the use of urine alkalinizing agents like potassium citrate or KetoCitra, may help slow the decline in kidney function and improve long-term outcomes.
Alkali-Rich Diets May Protect the Kidney in Early CKD
In a randomized controlled trial of 153 patients with stage G1 CKD and normal eGFR, dietary interventions that reduced acid load, either through increased consumption of fruits and vegetables or sodium bicarbonate, led to reductions in biomarkers of kidney injury over five years.
Although this study was not explicitly focused on ADPKD progression, its findings align with the broader view that dietary acid load has an impact on kidney health. An alkali-rich diet may be an easily accessible, low-risk strategy to help preserve kidney function in early stages of disease, including in genetically driven conditions like ADPKD.
The Bottom Line on Integrating Lifestyle for Slowing ADPKD Progression
Together, these studies reinforce a critical message: the progression of ADPKD is not solely determined by genes. Lifestyle factors, particularly body weight, dietary composition, and vigilance regarding silent complications, play a significant role in shaping outcomes.
While more long-term research is needed, the evidence already suggests an emerging paradigm in ADPKD care: one that combines genetic awareness with proactive, personalized lifestyle interventions. Patients and clinicians alike can take heart in knowing that the trajectory of this condition can, in part, be altered by informed, daily choices.
